Gerard Sanderink
Vice President & Global Head Laboratory Sciences Sanofi
Seminars
Thursday 25th September 2025
Impact of Current Regulations on Patients’ Timely Access to Drug-Diagnostics Clinical Trials & Case Study of a Newly Approved CDx for Qfitlia®
10:00 am
- Streamlining global clinical trials to meet regulatory demands depending on location
- Comparing IVDR and IDE
- FDA Approval of the Innovance® ATIII test as CDx for Qfitlia® (fitusiran) for Hemophilia patients
